Teva Pharmaceutical Industries Limited (TLV:TEVA)
6,252.00
-56.00 (-0.89%)
Oct 23, 2025, 5:28 PM IDT
Teva Pharmaceutical Industries Employees
As of December 31, 2024, Teva Pharmaceutical Industries had 35,686 total employees, including 33,892 full-time and 1,794 part-time employees. The number of employees decreased by 786 or -2.16% compared to the previous year.
Employees
35,686
Change (1Y)
-786
Growth (1Y)
-2.16%
Revenue / Employee
1.51M ILS
Profits / Employee
-14.30K ILS
Market Cap
71.30B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35,686 | -786 | -2.16% |
| Dec 31, 2023 | 36,472 | 1,347 | 3.83% |
| Dec 31, 2022 | 35,125 | -854 | -2.37% |
| Dec 31, 2021 | 35,979 | -2,393 | -6.24% |
| Dec 31, 2020 | 38,372 | -1,667 | -4.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Danel (Adir Yeoshua) | 4,290 |
| Novolog (Pharm-Up 1966) | 936 |
| Kamada | 420 |
| InterCure | 320 |
| Bait Bakfar | 227 |
| Ilex Medical | 178 |
| SofWave Medical | 126 |
| BrainsWay | 120 |
Teva Pharmaceutical Industries News
- 3 days ago - IDEV, AER, TEVA, GRAB: ETF Inflow Alert - Nasdaq
- 5 days ago - Formycon, Teva Pharma Launch FYB201/Ranivisio Biosimilar In Pre-filled Syringe In Europe - Nasdaq
- 5 days ago - Teva (TEVA) Partners with Prestige Biopharma for Tuznue in Europe - GuruFocus
- 5 days ago - Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe - GlobeNewsWire
- 9 days ago - Teva Vs. Viatris: Who Will Dominate In President Trump's America? - Seeking Alpha
- 10 days ago - AFI Development - Vedomosti (Ведомости)
- 13 days ago - TEVA Gets FDA Nod for Uzedy Label Expansion in Bipolar I Disorder - Nasdaq
- 15 days ago - Teva : FDA Grants Expanded Approval For UZEDY To Treat Bipolar I Disorder In Adults - Nasdaq